[1]
Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case control study. Lancet 2004; 364: 937-52.
[2]
Witteman JCM, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. BMJ 1989; 298: 642-4.
[3]
LaCroix AZ, Haynes SG, Savage DD, Havlik RJ. Rose questionnaire angina among United States black, white, and Mexican-American women and men. Am J Epidemiol 1989; 129: 669-86.
[4]
Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovic D. Low cigarette consumption and risk of coronary heart disease and stroke: Meta-analysis of 141 cohort studies in 55 study reports. BMJ 2018; 360: 5855.
[5]
Oliver MF, Boyd GS. Effect of bilateral ovariectomy on coronary artery disease and serum lipid levels. Lancet 1959; 2: 690-2.
[6]
Sznajderman M, Oliver MF. Spontaneous premature menopause, ischaemic heart disease and serum lipids. Lancet 1963; 1: 962-4.
[7]
Spencer CP, Godsland IF, Stevenson JC. Is there a menopausal metabolic syndrome? Gynecol Endocrinol 1997; 11: 341-55.
[8]
Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98: 83-90.
[9]
Anagnostis P, Stevenson JC, Crook D, Johnston DG, Godsland IF. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas 2015; 81: 62-8.
[10]
Ference BA, Ginsberg HN, Graham I, et al. Lipoproteins cause atherosclerotic cardiovascular disease. 1, Evidence from genetic, epidemiologic and clinical studies. A consensus statement from the European atherosclerosis society consensus panel. Eur Heart J 2017; 38: 2450-72.
[11]
Austin MA, Breslow JL, Hennekens CH, et al. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 26: 1917-21.
[12]
Carr MC, Kim KH, Zambon A, et al. Changes in LDL density across the menopausal transition. J Investig Med 2000; 48: 245-50.
[13]
Di Angelantonio E, Sarwar N, Perry P, et al. Emerging risk factors collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302: 1993-2000.
[14]
McBride P. Triglycerides and risk for coronary artery disease. Curr Atheroscler Rep 2008; 10: 386-90.
[15]
Danesh J, Collins R, Peto R. Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000; 102: 1082-5.
[16]
Anagnostis P, Karras S, Lambrinoudaki I, Stevenson JC, Goulis DG. Lipoprotein (a) in postmenopausal women: Assessment of cardiovascular risk and therapeutic options. Int J Clin Pract 2016; 70: 967-77.
[17]
Rönnemaa T, Laakso M, Pyörälä K, Kallio V, Puukka P. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and non-diabetic subjects. Arteriosclerosis 1991; 11: 80-90.
[18]
Ley CJ, Swan J, Godsland IF, et al. Insulin resistance, lipoproteins, body fat and hemostasis in non-obese males with angina and normal or abnormal coronary angiograms. J Am Coll Cardiol 1994; 23: 377-83.
[19]
Stout RW. Insulin and atheroma. 20-yr perspective. Diabetes Care 1990; 13: 631-54.
[20]
Båvenholm P, Proudler AJ, Tornvall P, et al. Insulin, intact and split proinsulin and coronary artery disease in young men. Circulation 1995; 92: 1422-9.
[21]
Krauss RM. The tangled web of coronary risk factors. Am J Med 1991; 90: 36-41.
[22]
Ferrannini E, Buzziogli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-7.
[23]
Juhan-Vague I, Alessi MC, Joly P, et al. Plasma plasminogen activator inhibitor 1 in angina pectoris. Influence of plasma insulin and acute-phase response. Arteriosclerosis 1989; 9: 362-7.
[24]
Stevenson JC, Lees B, Bruce R, Ley C, Crook D. Influence of body composition on lipid metabolism in postmenopausal women. In: Christiansen C, Overgaard K Eds Osteoporosis 1990,Osteopress. ApS: Copenhagen. 1990; pp. 1837-8.
[25]
Proudler AJ, Felton CV, Stevenson JC. Ageing and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women. Clin Sci 1992; 83: 489-94.
[26]
Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest 1993; 23: 466-73.
[27]
McCarty MF. A paradox resolved: The postprandial model of insulin resistance explains why gynoid adiposity appears to be protective. Med Hypotheses 2003; 61: 173-6.
[28]
Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am Jof Clin Nutr 1992; 55: 950-4.
[29]
Wiinber N, Hoegholm A, Christensen HR, et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995; 8: 978-86.
[30]
Lewington S, Clarke R, Qizilbash N, Peto R, Collions R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13.
[31]
Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens 1989; 3: 427-33.
[32]
Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension. Hypertension 2008; 51: 952-9.
[33]
Abbott W, Lillioja S, Young A. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinaemic population. Diabetes 1987; 36: 897-904.
[34]
Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study. BMJ 1983; 287: 867-70.
[35]
Park SK, Harlow SD, Zheng H, et al. Association between changes in oestradiol and folliclestimulating hormone levels during the menopausal transition and risk of diabetes. Diabet Med 2017; 34: 531-8.
[36]
Brand JS, van der Schouw YT, Onland-Moret NC, et al. InterAct Consortium. Age at menopause, reproductive life span, and type 2 diabetes risk: Results from the EPIC-InterAct study. Diabetes Care 2013; 36: 1012-9.
[37]
Shen L, Song L, Li H, et al. Association between earlier age at natural menopause and risk of diabetes in middle-aged and older Chinese women: The Dongfeng-Tongji cohort study. Diabetes Metab 2017; 43: 345-50.
[38]
Appiah D, Winters SJ, Hornung CA. Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women. Diabetes Care 2014; 37: 725-33.
[39]
LeBlanc ES, Kapphahn K, Hedlin H, et al. Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: Findings from the women’s health initiative. Menopause 2017; 24: 64-72.
[40]
Gangar KF, Vyas S, Whitehead M, et al. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338: 839-4.
[41]
Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28: 576-82.
[42]
Moreau KL, Hildreth KL, Meditz AL, Deane KD, Kohrt WM. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab 2012; 97: 4692-700.
[43]
Wingrove CS, Garr E, Pickar JH, Dey M, Stevenson JC. Effects of equine oestrogens on markers of vasoactive function in human coronary artery endothelial cells. Mol Cell Endocrinol 1999; 150: 33-7.
[44]
Wingrove CS, Stevenson JC. 17β-oestradiol inhibits stimulated endothelin release in human vascular endothelial cells. Eur J Endocrinol 1997; 137: 205-8.
[45]
Sturdee DW, Hunter MS, Maki PM, et al. The menopausal hot flush: A review. Climacteric 2017; 20: 296-305.
[46]
Collins P, Webb CM, De Villiers T, Stevenson J, Panay N, Baber R. Cardiovascular risk assessment in women - an update. Climacteric 2016; 19: 329-36.
